Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients

摘要

Background/AimsInsulin resistance (IR) plays an important role in the pathogenesis of diabetes and non-alcoholic fatty liver disease (NAFLD). Current methods for insulin resistance detection are cumbersome, or not sensitive enough for early detection and follow-up. The BreathID^® system can continuously analyse breath samples in real-time at the point-of-care. Here we determined the efficacy of the BreathID^® using the ¹³C-Glucose breath test (GBT) for evaluation of insulin resistance.